MIRA INFORM REPORT

 

 

Report No. :

314641

Report Date :

26.03.2015

 

IDENTIFICATION DETAILS

 

Name :

ITAL PHARCHEM S.R.L. 

 

 

Registered Office :

Via Per Cuggiono, 7,

20022 - Castano Primo (MI)

 

 

Country :

Italy

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

12.09.2006

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Engaged in Trading Pharmaceutical, Biological and Veterinary Products.

 

Subject operates through following business divisions:-

 

Active Pharmaceutical Ingredients Division

Engaged in the import/export of macrolides, mainly in the Middle East.

 

Excipients Division

Engaged as supplier of pharmaceutical excipients that are commonly used in the making of different types of drugs.

 

Fine Chemicals Division

Engaged in distributing reagents and "fine chemicals" for laboratories, as well as top quality and certified chemical raw materials for pharmaceutical companies

 

Finished Products  Division

Engaged in providing finished products in bulk in different categories, such as antibiotics, anti-malarial, analgesics, anti-pyretic, anti-hypertensives, anti-asthmatics, anti-epileptics, tranquilizers, anti-depressants & oncologicals

 

Nutraceuticals division

Engaged in providing NUTRACEUTICALS which are widely used to maintain the right balance of nutrients in the body ensuring the correct intake of RDA (Recommended Daily Allowance).

 

 

No of Employees :

01

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

Payment Behaviour :

Slow but Correct

Litigation :

Clear 

 


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Italy

A2

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

Italy ECONOMIC OVERVIEW

 

Italy has a diversified industrial economy, which is divided into a developed industrial north, dominated by private companies, and a less-developed, highly subsidized, agricultural south, where unemployment is higher. The Italian economy is driven in large part by the manufacture of high-quality consumer goods produced by small and medium-sized enterprises, many of them family-owned. Italy also has a sizable underground economy, which by some estimates accounts for as much as 17% of GDP. These activities are most common within the agriculture, construction, and service sectors. Italy is the third-largest economy in the euro-zone, but its exceptionally high public debt and structural impediments to growth have rendered it vulnerable to scrutiny by financial markets. Public debt has increased steadily since 2007, topping 133% of GDP in 2013, but investor concerns about Italy and the broader euro-zone crisis eased in 2013, bringing down Italy's borrowing costs on sovereign government debt from euro-era. The government still faces pressure from investors and European partners to sustain its efforts to address Italy's long-standing structural impediments to growth, such as labor market inefficiencies and widespread tax evasion. In 2013 economic growth and labor market conditions deteriorated, with growth at -1.8% and unemployment rising to 12.4%, with youth unemployment around 40%. Italy's GDP is now 8% below its 2007 pre-crisis level.

 

Source : CIA

 

 

Company name & address

 

Ital Pharchem S.r.l.

 

Via Per Cuggiono, 7

 

20022 - Castano Primo (MI) -IT-

Phone:             +39 0331 888422
Fax:                  + 39 0331 888445

Email:               info@italpharchem.it  
Website:           www.italpharchem.it

 

 

Summary

 

Fiscal Code

:

05419540967

Legal Form

:

Limited liability company

start of Activities

:

02/10/2006

Equity

:

200.000

Turnover Range

:

1.250.000/1.500.000

Number of Employees

:

01

 

 

Activity

 

Engaged in Trading Pharmaceutical, Biological and Veterinary Products.

 

Subject operates through following business divisions:-

 

Active Pharmaceutical Ingredients Division

Engaged in the import/export of macrolides, mainly in the Middle East.

 

Excipients Division

Engaged as supplier of pharmaceutical excipients that are commonly used in the making of different types of drugs.

 

Fine Chemicals Division

Engaged in distributing reagents and "fine chemicals" for laboratories, as well as top quality and certified chemical raw materials for pharmaceutical companies

 

Finished Products  Division

Engaged in providing finished products in bulk in different categories, such as antibiotics, anti-malarial, analgesics, anti-pyretic, anti-hypertensives, anti-asthmatics, anti-epileptics, tranquilizers, anti-depressants & oncologicals

 

Nutraceuticals division

Engaged in providing NUTRACEUTICALS which are widely used to maintain the right balance of nutrients in the body ensuring the correct intake of RDA (Recommended Daily Allowance).

Legal Data

 

Legal Form :                                                     Limited liability company

Fiscal Code :                                                            05419540967

Vat:                                                                       11997650152

Chamber of Commerce no. :                              1820861 of Milano since 02/10/2006

Establishment date

: 12/09/2006

Start of Activities

: 02/10/2006

Legal duration

: 31/12/2020

Nominal Capital

: 20.000

Subscribed Capital

: 20.000

Paid up Capital

: 20.000

 

Members

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Afsar

Mahmoud Reza

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Vuoto.gif

Born in Esfahan

( )

on 19/10/1952

- Fiscal Code : FSRMMD52R19Z224C

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Vuoto.gif

Residence:

Diaz

, 46

- 20020

Magnago

(MI)

- IT -

 

Position

Since

Shares Amount

% Ownership

Sole Director

12/09/2006

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Vuoto.gif

No Prejudicial events are reported

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Vuoto.gif

No Protests registered

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Rabiee Majid

 

 

Position

Since

Shares Amount

% Ownership

Partner

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Vuoto.gif

No Prejudicial events are reported

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Vuoto.gif

No Protests registered

 

Companies connected to members *

 

*checkings have been performed on a national scale.

 

In this module are listed the companies in which members hold or have holded positions.

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Afsar

Mahmoud Reza

 

Firm's Style

Seat

Fiscal Code

Position

Position Status

Firm's Status

AFSAR Trade di Asfar Mahmoud Reza

Magnago (MI) - IT -

FSRMMD52R19Z224C

Proprietor

Withdrawn

Registered

Sitindustrie Valvometal - Ital Parts Group Srl

Castano Primo (MI) - IT -

11997650152

Director

Active

Registered

Sitindustrie Valvometal - Ital Parts Group Srl

Castano Primo (MI) - IT -

11997650152

Partner

Withdrawn

Registered

Sitindustrie Valvometal - Ital Parts Group Srl

Castano Primo (MI) - IT -

11997650152

Board Chairman

Active

Registered

Ital Petrochem S.r.l.

Castano Primo (MI) - IT -

06037940969

Sole Director

Withdrawn

Registered

 

The indication "REGISTERED" as Firm Status could refer to Firms in Liquidation, Active, Inactive, etc.

 

For more information, in this case, we advise to request further investigations.

 

Capital Shareholders

 

Shareholders' list as at date of data collection:

Firm's Style / Name

Seat / Residence

Fiscal Code

Owned Shares

% Ownership

Afsar Mahmoud Reza

Magnago - IT -

FSRMMD52R19Z224C

8.400 .Eur

42,00

Eghlima Morteza

GHLMTZ54L05Z224W

2.000 .Eur

10,00

Rabiee Majid

RBAMJD73M05Z224I

9.600 .Eur

48,00

 

Direct Participations

 

The Company under review has no participations in other Companies.

 

Firm's location and structure

 

In order to carry out its activities the firm uses the following locations:

 

-

Legal and operative seat

 

Per Cuggiono

, 7

- 20022

- Castano Primo

(MI)

- IT -

Phone:             +39 0331 888422
Fax:                  + 39 0331 888445

Email:               info@italpharchem.it  
Website:           www.italpharchem.it

 

Employees

: 1

 

Protests

 

Protests checking on the subject firm has given a negative result.

 

Data Base Prejudicial Events Search

 

Search performed on a National Scale

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Prejudicial Events Search Result: NEGATIVE

 

Search performed on a specialized data base.

 

Legal Procedures

 

None reported, standing to the latest received edition of the Official Publications.

 

Financial and Economical Analysis

 

Subject is active since 2006

The economic-financial analysis is based on the latest 3 b/s.

During the last years, it recorded positive net results (r.o.e. 10,67% in 2013) but without a significant increase in the turnover.

The operating result was positive in the last financial year (3%) falling within the field's average.

The amount of the operating result is equal to Eur. 29.771 recording a drop as opposed to the year before (-33,78%).

The economic management produced a gross operating margin of Eur. 39.470 recording a -27,79% decrease.

The ratio between shareholder's equity and borrowed capital is not well balanced, the indebtedness level is equal to 4,26 which is decreasing.

With regard to equity capital, an amount of Eur. 156.408 is registered. on stable levels.

Eur. 835.048 is the amount of total debts, both commercial and of different nature, , with a fall of -39,74%.

Liquidity is good.

The financial management generated a cash flow of Eur. 26.381.

The incidence of the financial charges is of -0,21% on the sales amount.


Financial Data

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Complete balance-sheet for the year

al 31/12/2013

(in Eur

x 1)

 

Item Type

Value

Sales

1.286.733

Profit (Loss) for the period

16.682

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Complete balance-sheet for the year

al 31/12/2012

(in Eur

x 1)

 

Item Type

Value

Sales

1.383.995

Profit (Loss) for the period

28.979

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Complete balance-sheet for the year

al 31/12/2011

(in Eur

x 1)

 

Item Type

Value

Sales

1.610.929

Profit (Loss) for the period

43.017

 

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Verde.gif

Complete balance-sheet for the year

al 31/12/2010

(in Eur

x 1)

 

Item Type

Value

Sales

508.150

Profit (Loss) for the period

24.985


Balance Sheets

 

From our constant monitoring of the relevant Public Administration offices, no more recent balance sheets result to have been filed.

 

- Balance Sheet as at 31/12/2013 - 12 Mesi - Currency: - Amounts x 1

 

- Balance Sheet as at 31/12/2012 - 12 Mesi - Currency: - Amounts x 1

 

- Balance Sheet as at 31/12/2011 - 12 Mesi - Currency: - Amounts x 1

 

Years

2013

2012

2011

BALANCE SHEET ACCOUNTS

 

ASSETS

CREDITS VS PARTNERS

. Deposits not yet withdrawn

. Deposits already withdrawn

Total credits vs partners

FIXED ASSETS

. INTANGIBLE FIXED ASSETS

. . Start-up and expansion expenses

. . Research,develop. and advert.expens.

. . Industrial patent rights

. . Concessions,licenses,trademarks,etc.

. . Goodwill

. . Assets in formation and advance paymen.

. . Other intangible fixed assets

. Total Intangible Fixed Assets

103.592

113.291

122.991

. TANGIBLE FIXED ASSETS

. . Real estate

. . Plant and machinery

. . Industrial and commercial equipment

. . Other assets

. . Assets under construction and advances

. Total Tangible fixed assets

. FINANCIAL FIXED ASSETS

. . Equity investments

. . . Equity invest. in subsidiary companies

. . . Equity invest. in associated companies

. . . Equity invest. in holding companies

. . . Equity invest. in other companies

. . Financial receivables

. . . . Within 12 months

. . . . Beyond 12 months

. . . Receivab due from subsidiaries

. . . . Within 12 months

. . . . Beyond 12 months

. . . Receivables due from assoc.comp.

. . . . Within 12 months

. . . . Beyond 12 months

. . . Receivables due from holding comp.

. . . . Within 12 months

. . . . Beyond 12 months

. . . Receivables due from third parties

. . . . Within 12 months

. . . . Beyond 12 months

. . Other securities

. . Own shares

. . . Total nominal value

. Total financial fixed assets

Total fixed assets

103.592

113.291

122.991

CURRENT ASSETS

. INVENTORIES

. . Raw materials and other consumables

. . Work in progress and semimanufactured

. . Work in progress on order

. . Finished goods

. . Advance payments

. Total Inventories

. CREDITS NOT HELD AS FIXED ASSETS

. . Within 12 months

718.729

1.043.719

870.646

. . Beyond 12 months

. . Trade receivables

. . . . Within 12 months

. . . . Beyond 12 months

. . Receivables due from subsid. comp.

. . . . Within 12 months

. . . . Beyond 12 months

. . Receivables due from assoc. comp.

. . . . Within 12 months

. . . . Beyond 12 months

. . Receivables due from holding comp.

. . . . Within 12 months

. . . . Beyond 12 months

. . Fiscal Receivables

. . . . Within 12 months

. . . . Beyond 12 months

. . Receivables for anticipated taxes

. . . . Within 12 months

. . . . Beyond 12 months

. . Receivables due from third parties

. . . . Within 12 months

. . . . Beyond 12 months

. Total Credits not held as fixed assets

718.729

1.043.719

870.646

. FINANCIAL ASSETS

. . Equity invest. in subsidiary comp.

. . Equity invest. in associated companies

. . Equity invest. in holding companies

. . Other equity investments

. . Own shares

. . . Total nominale value

. . Other securities

. Total Financial Assets

. LIQUID FUNDS

. . Bank and post office deposits

. . Checks

. . Banknotes and coins

. Total Liquid funds

169.150

368.714

240.812

Total current assets

887.879

1.412.433

1.111.458

ADJUSTMENT ACCOUNTS

. Discount on loans

. Other adjustment accounts

86

Total adjustments accounts

86

TOTAL ASSETS

991.471

1.525.724

1.234.535

LIABILITIES

STOCKHOLDERS' EQUITY

. Capital stock

20.000

20.000

20.000

. Additional paid-in capital

. Revaluation reserves

. Legal reserve

4.000

4.000

3.932

. Reserve for Own shares

. Statute reserves

. Other reserves

-1

2

. Accumulated Profits (Losses)

115.726

86.747

43.798

. Profit( loss) of the year

16.682

28.979

43.017

. Advances on dividends

. Partial loss of the year Coverage

Total Stockholders'Equity

156.408

139.725

110.749

RESERVES FOR RISKS AND CHARGES

. . Reserve for employee termination indem.

. . Taxation fund, also differed

. . Other funds

Total Reserves for Risks and Charges

Employee termination indemnities

7.017

ACCOUNTS PAYABLE

. . . . Within 12 months

835.048

1.385.884

1.116.746

. . . . Beyond 12 months

. . Bonds

. . . . Within 12 months

. . . . Beyond 12 months

. . Convertible bonds repayable

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to shareholders for financing

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to banks

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to other providers of finance

. . . . Within 12 months

. . . . Beyond 12 months

. . Advances from customers

. . . . Within 12 months

. . . . Beyond 12 months

. . Trade payables

. . . . Within 12 months

. . . . Beyond 12 months

. . Securities issued

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to subsidiary companies

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to associated companies

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to holding companies

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to the tax authorities

. . . . Within 12 months

. . . . Beyond 12 months

. . Due to social security and welfare inst.

. . . . Within 12 months

. . . . Beyond 12 months

. . Other payables

. . . . Within 12 months

. . . . Beyond 12 months

Total accounts payable

835.048

1.385.884

1.116.746

ADJUSTMENT ACCOUNTS

. Agio on loans

. Other adjustment accounts

15

115

23

Total adjustment accounts

15

115

23

TOTAL LIABILITIES

991.471

1.525.724

1.234.535

 

 

PROFIT AND LOSS ACCOUNTS

 

VALUE OF PRODUCTION

. Revenues from sales and services

1.286.733

1.383.995

1.610.929

. Changes in work in progress

. Changes in semi-manufact. products

. Capitalization of internal work

. Other income and revenues

1

596

206

. . Contributions for operating expenses

. . Different income and revenues

1

596

206

Total value of production

1.286.734

1.384.591

1.611.135

PRODUCTION COSTS

. Raw material,other materials and consum.

1.079.715

1.159.850

1.289.270

. Services received

. Leases and rentals

115.645

168.798

221.732

. Payroll and related costs

24.391

. . Wages and salaries

16.947

. . Social security contributions

5.318

. . Employee termination indemnities

1.396

. . Pension and similar

. . Other costs

730

. Amortization and depreciation

9.699

9.699

9.699

. . Amortization of intangible fixed assets

9.699

9.699

9.699

. . Amortization of tangible fixed assets

. . Depreciation of tangible fixed assets

. . Writedown of current receiv.and of liquid

. Changes in raw materials

. Provisions to risk reserves

. Other provisions

. Other operating costs

51.904

1.281

3.578

Total production costs

1.256.963

1.339.628

1.548.670

Diff. between value and cost of product.

29.771

44.963

62.465

FINANCIAL INCOME AND EXPENSE

. Income from equity investments

. . In subsidiary companies

. . In associated companies

. . In other companies

. Other financial income

2.502

1.538

883

. . Financ.income from receivables

. . . Towards subsidiary companies

. . . Towards associated companies

. . . Towards holding companies

. . . Towards other companies

. . Financ.income from secur. t.f.assets

. . Financ.income from secur. cur.assets

. . Financ.income other than the above

2.502

1.538

883

. . . - Subsidiary companies

. . . - Associated companies

. . . - Holding companies

. . . - Other companies

2.502

1.538

883

. Interest and other financial expense

-5.233

-4.429

437

. . Towards subsidiary companies

. . Towards associated companies

. . Towards holding companies

. . Towards other companies

5.233

4.429

-437

Total financial income and expense

-2.731

-2.891

1.320

ADJUSTMENTS TO FINANCIAL ASSETS

. Revaluations

. . Of equity investments

. . Of financ.fixed assets not repres.E.I.

. . Of securities incl.among current assets

. Devaluation

. . Of equity investments

. . Of financial fixed assets (no equity inv)

. . Of securities included among current ass

Total adjustments to financial assets

EXTRAORDINARY INCOME AND EXPENSE

. Extraordinary income

. . Gains on disposals

. . Other extraordinary income

. Extraordinary expense

. . Losses on disposals

. . Taxes relating to prior years

. . Other extraordinary expense

Total extraordinary income and expense

-2

-1

-1

Results before income taxes

27.038

42.071

63.784

. Taxes on current income

10.356

13.092

20.767

. . current taxes

10.356

13.092

20.767

. . differed taxes(anticip.)

. Net income for the period

16.682

28.979

43.017

. Adjustments in tax regulations pursuance

. Provisions in tax regulations pursuance

. Profit (loss) of the year

16.682

28.979

43.017

 

RATIOS

Value Type

as at 31/12/2013

as at 31/12/2012

as at 31/12/2011

Sector Average

COMPOSITION ON INVESTMENT

Rigidity Ratio

Units

0,10

0,07

0,10

0,09

Elasticity Ratio

Units

0,90

0,93

0,90

0,89

Availability of stock

Units

n.c.

n.c.

n.c.

0,26

Total Liquidity Ratio

Units

0,90

0,93

0,90

0,54

Quick Ratio

Units

0,17

0,24

0,20

0,03

COMPOSITION ON SOURCE

Net Short-term indebtedness

Units

4,26

7,28

7,91

3,95

Self Financing Ratio

Units

0,16

0,09

0,09

0,17

Capital protection Ratio

Units

0,77

0,65

0,43

0,62

Liabilities consolidation quotient

Units

n.c.

n.c.

0,01

0,10

Financing

Units

5,34

9,92

10,08

4,85

Permanent Indebtedness Ratio

Units

0,16

0,09

0,10

0,29

M/L term Debts Ratio

Units

n.c.

n.c.

0,01

0,07

Net Financial Indebtedness Ratio

Units

n.c.

n.c.

n.c.

1,04

CORRELATION

Fixed assets ratio

Units

1,51

1,23

0,96

2,37

Current ratio

Units

1,06

1,02

1,00

1,18

Acid Test Ratio-Liquidity Ratio

Units

1,06

1,02

1,00

0,80

Structure's primary quotient

Units

1,51

1,23

0,90

1,48

Treasury's primary quotient

Units

0,20

0,27

0,22

0,04

Rate of indebtedness ( Leverage )

%

633,90

1091,95

1114,71

602,26

Current Capital ( net )

Value

52.831

26.549

-5.288

191.984

RETURN

Return on Sales

%

2,05

2,79

3,27

2,03

Return on Equity - Net- ( R.O.E. )

%

10,67

20,74

38,84

6,31

Return on Equity - Gross - ( R.O.E. )

%

17,29

30,11

57,59

17,00

Return on Investment ( R.O.I. )

%

3,00

2,95

5,06

4,18

Return/ Sales

%

2,31

3,25

3,88

3,46

Extra Management revenues/charges incid.

%

56,03

64,45

68,87

27,96

Cash Flow

Value

26.381

38.678

52.716

44.823

Operating Profit

Value

29.771

44.963

62.465

74.603

Gross Operating Margin

Value

39.470

54.662

72.164

111.383

MANAGEMENT

Credits to clients average term

Days

n.c.

n.c.

n.c.

113,70

Debts to suppliers average term

Days

n.c.

n.c.

n.c.

118,14

Average stock waiting period

Days

n.c.

n.c.

n.c.

72,90

Rate of capital employed return ( Turnover )

Units

1,30

0,91

1,30

1,25

Rate of stock return

Units

n.c.

n.c.

n.c.

4,88

Labour cost incidence

%

n.c.

n.c.

1,51

8,14

Net financial revenues/ charges incidence

%

-0,21

-0,21

0,08

-1,38

Labour cost on purchasing expenses

%

n.c.

n.c.

1,57

8,25

Short-term financing charges

%

0,63

0,32

n.c.

2,76

Capital on hand

%

77,05

110,24

76,63

79,85

Sales pro employee

Value

397.742

Labour cost pro employee

Value

33.267

 

Market / Territory Data

 

Population living in the province

:

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Spazio.gif3.839.216

Population living in the region

:

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Spazio.gif9.393.092

Number of families in the region

:

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Spazio.gif3.858.736

 

Monthly family expenses average in the region (in Eur..) :

 

- per food products

:

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Spazio.gif460

- per non food products

:

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Spazio.gif2.090

- per energy consume

:

Description: C:\Users\605-13\AppData\Local\Temp\Rar$EXa0.377\Spazio.gif114

 

Sector Data

 

The values are calculated on a base of 9.175 significant companies.

The companies cash their credits on an average of 114 dd.

The average duration of suppliers debts is about 118 dd.

The sector's profitability is on an average of 2,03%.

The labour cost affects the turnover in the measure of 8,14%.

Goods are held in stock in a range of 73 dd.

The difference between the sales volume and the resources used to realize it is about 1,25.

The employees costs represent the 8,25% of the production costs.

 

Statistical Detrimental Data

 

Statistically the trade activity shows periods of crisis.

The area is statistically considered lowly risky.

In the region 50.886 protested subjects are found; in the province they count to 24.765.

The insolvency index for the region is 0,55, , while for the province it is 0,66.

Total Bankrupt companies in the province : 22.523.

Total Bankrupt companies in the region : 39.612.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.34

UK Pound

1

Rs.92.65

Euro

1

Rs.68.12

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.